Prices delayed by at least 15 minutes | Print
Astrazeneca PLC (AZN)
ORD SHS $0.25Open
12326p
Previous close
12370p
Trade high
12428p
Volume
176,871
Year high
12,488.00p
Year low
9,461.00p
Dividend yield
1.84%
Market capitalisation
£191.17 bn
P/E ratio
38.25
ISIN
GB0009895292
This share can be held in a Dealing accountISALifetime ISAJISASIPPand can be used with Regular investment and Dividend reinvestment
Share price
Dividends
Previous | Latest | |
---|---|---|
Record date | 11/08/2023 | 23/02/2024 |
Ex-dividend date | 10/08/2023 | 22/02/2024 |
Payment date | 11/09/2023 | 25/03/2024 |
Amount | 71.80p | 156.00p |
Company profile
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its revenue.
News
Recent trades
Date | Time | Price | Quantity | Value (£) |
---|---|---|---|---|
13/05/2024 | 10:32:49 | 12328 | 42 | 5,177.76 |
13/05/2024 | 10:32:20 | 12328 | 8 | 986.24 |
13/05/2024 | 10:32:03 | 12328 | 30 | 3,698.40 |
13/05/2024 | 10:32:00 | 12330 | 56 | 6,904.80 |
13/05/2024 | 10:32:00 | 12330 | 37 | 4,562.10 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.